Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Repligen Corporation

Bio Collectors is a food waste collection company that transforms commercial food waste into energy and biogas for businesses and communities. It operates a closed-loop food waste recycling system.

Bio Collectors

Biotech 365 provides business support services for biotech companies, focusing on fundraising, licensing, and connecting companies with healthcare investors through their global network.

Biotech 365

Power And Energy Services provides sales, service, and solutions for power generation equipment including generators, UPS, fuel cells, engines, turbines, HVAC, switchgear, and transfer switches. The company operates in emergency back-up systems and maintenance.

Power And Energy Services

Repligen provides technology breakthroughs and scalable solutions for the development and manufacture of biologic drugs including plasmid DNA, viral vectors, and mRNA, self-described as a trusted partner in bioprocessing.

Metric
Company Name	Repligen Corporation	Bio Collectors	Biotech 365	Power And Energy Services
Symbol	RGEN
MSH ID	COM:REPLIGEN	COM:BIOCOLLECTORS	COM:BIOTECH-365	COM:PANDESERVICES
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Consumer Services	Financial Services & Finance	Commercial & Professional Services
Industry	Medical - Instruments & Supplies	Waste Management	Biotechnology Business Services	Energy Services
Country	US	GB	FR	US
Stage
Employee Count	1.78K
Website	repligen.com	biocollectors.com	biotech-365.com	pandeservices.com
LinkedIn		biocollectors
Founders

Metric
Market Cap	6.76B
Enterprise Value
Monthly Web Traffic		68
Web Traffic Growth		-0.57
Valuation
Raised Capital

Metric
Revenue	638.76M
Revenue (LTM)
Revenue (NTM)
Gross Profit	284.25M
EBITDA	131.39M
Operating Income	63.31M
Net Income	41.58M
EPS	0.75
Diluted EPS	0.74
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.55
Operating Profit Margin	0.09
EBITDA Margin	0.21
Net Profit Margin	0.07
Return on Equity	0.05
Return on Assets	0.01
Return on Capital Employed	0.02

COM:REPLIGEN

Repligen

Last Close

141.76

22/11 21:00

Market Cap

6.76B

Beta: -

Volume Today

556.88K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	94.12
P/B Ratio	23.47
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	17.43
EV Multiple	1.27K

Metric
Days Sales Outstanding	57.85
Days Payables Outstanding	19.41
Days Inventory Outstanding	258.37
Operating Cycle	333.05
Cash Conversion Cycle	304.69
Asset Turnover	0.23

Metric
Operating Cash Flow	113.92M
Free Cash Flow	74.93M
Cash Flow to Debt	0.26
Operating Cash Flow/Sales	0.26
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	751.32M
Accounts Receivable	-3.31M
Inventory	202.32M
Goodwill	987.12M
Debt to Capitalization	0.27
Debt to Assets	0.17
Current Ratio	2.69
Quick Ratio	13.45

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.04
R&D to Revenue	0.07
SG&A to Revenue